|
|
|
Volumn 39, Issue 3, 2000, Pages 232-234
|
|
Cost-effectiveness of non-steroidal anti-inflammatory drugs (NSAIDs) - What makes a NSAID good value for money?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
DICLOFENAC;
IBUPROFEN;
MISOPROSTOL;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROTON PUMP INHIBITOR;
ROFECOXIB;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
EDITORIAL;
GASTROINTESTINAL SYMPTOM;
HUMAN;
META ANALYSIS;
OSTEOARTHRITIS;
PRIORITY JOURNAL;
STOMACH PROTECTION;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ARTHRITIS, RHEUMATOID;
CONTROLLED CLINICAL TRIALS;
COST-BENEFIT ANALYSIS;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
GREAT BRITAIN;
HUMANS;
ISOENZYMES;
MEMBRANE PROTEINS;
OSTEOARTHRITIS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
|
|
EID: 0034090391
PISSN: 14620324
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (7)
|
|
References (6)
|